g10 fx
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00 - AD HOC NEWS
Citi
From the original
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00 AD HOC NEWS
Related speeches
4 itemsChugai returned emugrobart rights and Chugai Pharmaceutical stock costs EUR 34.54 - AD HOC NEWS
Citi cuts Mitsubishi Electric target to ¥7,200, keeps buy rating - Investing.com
Citi cuts Mitsubishi Electric target to ¥7,200, keeps buy rating By Investing.com - Investing.com India
Citi cuts Mitsubishi Electric target to ¥7,200, keeps buy rating By Investing.com - Investing.com Australia
More like this
5 itemsJPMorgan previews Japan's IT services and telecom earnings season: Cybersecurity takes center stage, while overlooked stocks await a rebound - Moomoo
Equities: AI concerns pressure stocks as futures rise – Deutsche Bank - www.tmgm.com
Equities: Bond stress triggers global stock retreat - Deutsche Bank - www.tmgm.com
EUR/JPY Price Forecast: Tests 177.50 barrier near nine-day EMA - Mitrade